Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or post-transplant recurrence: phase 3 ALLY-1 study - Poordad, F; Schiff, E; Vierling, J (J Viral Hepatitis, 2015)
et al.